Schedule 13G ownership disclosure
X4 PHARMACEUTICALS INC
Security class unavailable · CUSIP: 98420X103
Event date: 2019-04-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-19-000298
- Form type
- SC 13G
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Apr 19, 2019
- Reporting period
- Apr 16, 2019
- Description
- Schedule 13G beneficial ownership